Constipation Pipeline Review, H2 2018 - Therapeutic Assessment of 17 Companies & Drug Profiles - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Constipation - Pipeline Review, H2 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.

Constipation - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Constipation (Gastrointestinal), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Constipation (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Constipation and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical and Discovery stages are 4, 4, 8, 2, 2 and 1 respectively. Similarly, the Universities portfolio in Discovery stages comprises 1 molecules, respectively.

Constipation (Gastrointestinal) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Key Topics Covered:

1. Introduction
2. Report Coverage
3. Constipation - Overview
4. Constipation - Therapeutics Development
5. Pipeline Overview
6. Pipeline by Companies
7. Pipeline by Universities/Institutes
8. Products under Development by Companies
9. Products under Development by Universities/Institutes
10. Constipation - Therapeutics Assessment
11. Assessment by Target
12. Assessment by Mechanism of Action
13. Assessment by Route of Administration
14. Assessment by Molecule Type
15. Constipation - Companies Involved in Therapeutics Development

• Allergan Plc
• Ardelyx Inc
• Braintree Laboratories Inc
• Dong-A ST Co Ltd
• EA Pharma Co Ltd
• Ironwood Pharmaceuticals Inc
• Johnson & Johnson
• MallInckrodt Plc
• NGM Biopharmaceuticals Inc
• RaQualia Pharma Inc
• Sanwa Kagaku Kenkyusho Co Ltd
• SK Biopharmaceuticals Co Ltd
• Sumitomo Dainippon Pharma Co Ltd
• Synthetic Biologics Inc
• Vanda Pharmaceuticals Inc
• Yuhan Corp
• Zensun (Shanghai) Sci & Tech Co Ltd

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/73czxj/constipation?w=4